Six chalcone compounds, 2′,4′,4-trihydroxy-3′-[2-hydroxy-7-methyl-3-methylene-6-octaenyl]chalcone (1), 2′,4′,4-trihydroxy-3′-geranylchalcone (2), 2′,4′,4-trihydroxy-3′-[6-hydroxy-3,7-dimethyl-2,7-octadienyl]chalcone (3), 2′,4-dihydroxy-4′-methoxy-3′-[2-hydroperoxy-3-methyl-3-butenyl]chalcone (4), 2′,4-dihydroxy-4′-methoxy-3′-geranylchalcone (5), and 2′,4-dihydroxy-4′-methoxy-3′-[3-methyl-3-butenyl]chalcone (6) were isolated from the leaves of Angelica keiskei K (Umbelliferae). The structure of each isolated compound was determined using spectroscopic methods. Among the isolates, compounds 1–3 appeared to have potent inhibitory activity of IL-6 production in TNF-α-stimulated MG-63 cell, while compounds 4–6 did not. The distinct structural difference between compounds 1–3 and 4–6 was the presence of C-4′ hydroxyl group in the chalcone moiety. Our results imply that the inhibitory activity of IL-6 production in TNF-α-stimulated MG-63 cell may be affected by the presence of C-4′ hydroxyl group in the chalcone moiety.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Akihisa, T., Tokuda, H., Ukiya, M., Iizuka, M., Schneider, S., Ogasawara, K., Mukainaka, T., Iwatsuki, K., Suzuki, T., and Nishino, H., Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects. Cancer Lett., 201, 133–137 (2003).
Akihisa, T., Tokuda, H., Hasegawa, D., Ukiya, M., Kimura, Y., Enjo, F., Suzuki, T., and Nishino, H., Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects. J. Nat. Prod., 69, 38–42 (2006).
Aoki, N., Muko, M., Ohta, E., and Ohta, S., C-geranylated chalcones from the stems of Angelica keiskei with superoxide-scavenging activity. J. Nat. Prod., 71, 1308–1310 (2008).
Baba, K., Najata, K., Taniguchi, M., Kido, T., and Kozawa, M., Chalcones from Angelica keikei. Phytochemistry, 29, 3907–3910 (1990).
Enoki, T., Ohnogi, H., Nagamine, K., Kudo, Y., Sugiyama, K., Tanabe, M., Kobayashi, E., Sagawa, H., and Kato, I., Antidiabetic activities of chalcones isolated from a Japanese Herb, Angelica keiskei. J. Agric. Food Chem., 55, 6013–6017 (2007).
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwamatsu, A., Tsunsawa, S., Sakiyama, F., Matsui, H., Takahara, Y., Taniguchi, T., and Kishimoto, T., Complementary DNA for a novel human interleukin (BSF-2) that induced lymphocytes to produce immunoglobulin. Nature, 324, 73–76 (1986).
Hirano, T., Akira, S., Taga, T., and Kishimoto, T., Biological and clinical aspects of interleukin 6. Immunol. Today, 11, 443–449 (1990).
Jayasinghe, L., Balasooriya, B. A. I. S., Padmini, W. C., Hara, N., and Fujimoto, Y., Geranyl chalcone derivatives with antifungal and radical scavenging properties from the leaves of Arctocarpus nobilis. Phytochemistry, 65, 1287–1290 (2004).
Kim, B. H., Chung, E. Y., Ryu, J.-C., Jung, S.-H., Min, K. R., and Kim, Y., Anti-inflammatory mode of isoflavone glycosides sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response. Arch. Pharm. Res., 26, 306–311 (2003).
Kimura, Y., Taniguchi, M., and Baba, K., Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots. Planta Med., 70, 211–219 (2004).
Kimura, Y., New anticancer agents: in vitro and in vivo evaluation of the antitumor and antimetastatic actions of various compounds isolated from medicinal plants. In Vivo, 19, 37–60 (2005).
Kimura, Y., Sumiyoshi, M., and Baba, K., Anti-tumor actions of major component 3′-O-acetylhamaudol of Angelica japonica roots through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation. Cancer Lett., 265, 84–97 (2008).
Kozawa, M., Morita, N., Baba, K., and Hata, K., The structure of xanthoangelol, a new chalcone from the roots of Angelica keiskei K. (Umbelliferae). Chem. Pharm. Bull., 25, 515–516 (1977).
Kozawa, M., Morita, N., Baba, K., and Hata, K., Chemical components of the roots of Angelica keiskei Koidzumi. II. The structure of the chalcone derivatives. Yakugaku Zasshi, 98, 210–214 (1978).
Lee, H. J., Choi, T. W., Kim, H. J., Nam, D., Jung, S. H., Lee, E. H., Lee, H. J., Shin, E. M., Jang, H. J., Ahn, K. S., Shim, B. S., Choi, S. H., Kim, S. H., Sethi, G., and Ahn, K. S., Anti-Inflammatory activity of Angelica keiskei through suppression of mitogen-activated protein kinases and nuclear factor-kappa B activation pathways. J. Med. Food, 13, 691–699 (2010).
Liu, Q. H., Jeong, J.-E., Choi, E. J., Moon, Y. H., and Woo, E.-R., A new furofuran lignan from Geranium thunbergii. Arch. Pharm. Res., 29, 1109–1113 (2006).
Motani, K., Tabata, K., Kimura, Y., Okano, S., Shibata, Y., Abiko, Y., Nagai, H., Akihisa, T., and Suzuki, T., Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma. Biol. Pharm. Bull., 31, 618–626 (2008).
Nakata, K., Taniguchi, M., and Baba, K., Three chalcones from Angelica keiskei. Nat. Med., 53, 329–332 (1999).
Nishimura, R., Tabata, K., Arakawa, M., Ito, Y., Kimura, Y., Akihisa, T., Nagai, H., Sakuma, A., Kohno, H., and Suzuki, T., Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma. Biol. Pharm. Bull., 30, 1878–1883 (2007).
Tabata, K., Motani, K., Takayanagi, N., Nishimura, R., Asami, S., Kimura, Y., Ukiya, M., Hasegawa, D., Akihisa, T., and Suzuki, T., Xanthoangelol, a major chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma and leukemia cells. Biol. Pharm. Bull., 28, 1404–1407 (2005).
Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., and Van Snick. J., Identification of the human 26-kD protein, interferon beta 2(IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced in interleukin 1 and tumor necrosis factor. J. Exp. Med., 165, 914–919 (1987).
Webb, S. J., McPherson, J. R., Pahan, K., and Koka, S., Regulation of TNF-alpha-induced IL-6 production in MG-63 human osteoblast-like cells. J. Dent. Res., 81, 17–22 (2002).
About this article
Cite this article
Shin, J.E., Choi, E.J., Jin, Q. et al. Chalcones isolated from Angelica keiskei and their inhibition of IL-6 production in TNF-α-stimulated MG-63 cell. Arch. Pharm. Res. 34, 437–442 (2011). https://doi.org/10.1007/s12272-011-0311-0
- Angelica keiskei koidzumi
- C-geranylated chalcone
- IL-6 inhibitory activity